Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
Go back to Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026| (NASDAQ: MNPR) | Delayed: 95.72 -0.75 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $96.47 | 52 Week High | $ | |||
| Open | $97.92 | 52 Week Low | $ | |||
| Day High | $98.19 | P/E | N/A | |||
| Day Low | $94.95 | EPS | $ | |||
| Volume | 89,238 | |||||

